Cite
Linezolid in the treatment of severe central nervous system infections resistant to recommended antimicrobial compounds.
MLA
Sabbatani, Sergio, et al. “Linezolid in the Treatment of Severe Central Nervous System Infections Resistant to Recommended Antimicrobial Compounds.” Le Infezioni in Medicina, vol. 13, no. 2, June 2005, pp. 112–19. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=16220032&authtype=sso&custid=ns315887.
APA
Sabbatani, S., Manfredi, R., Frank, G., & Chiodo, F. (2005). Linezolid in the treatment of severe central nervous system infections resistant to recommended antimicrobial compounds. Le Infezioni in Medicina, 13(2), 112–119.
Chicago
Sabbatani, Sergio, Roberto Manfredi, Giorgio Frank, and Francesco Chiodo. 2005. “Linezolid in the Treatment of Severe Central Nervous System Infections Resistant to Recommended Antimicrobial Compounds.” Le Infezioni in Medicina 13 (2): 112–19. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=16220032&authtype=sso&custid=ns315887.